Compare NRO & SENS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NRO | SENS |
|---|---|---|
| Founded | 2003 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Industrial Machinery/Components |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 199.6M | 225.5M |
| IPO Year | N/A | N/A |
| Metric | NRO | SENS |
|---|---|---|
| Price | $3.04 | $5.87 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $25.58 |
| AVG Volume (30 Days) | 239.4K | ★ 434.8K |
| Earning Date | 01-01-0001 | 11-05-2025 |
| Dividend Yield | ★ 11.41% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $29,298,000.00 |
| Revenue This Year | N/A | $59.55 |
| Revenue Next Year | N/A | $70.49 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 31.94 |
| 52 Week Low | $2.51 | $5.25 |
| 52 Week High | $3.45 | $28.00 |
| Indicator | NRO | SENS |
|---|---|---|
| Relative Strength Index (RSI) | 54.56 | 46.59 |
| Support Level | $2.91 | $5.41 |
| Resistance Level | $3.06 | $6.44 |
| Average True Range (ATR) | 0.03 | 0.35 |
| MACD | 0.02 | -0.14 |
| Stochastic Oscillator | 83.33 | 27.38 |
NEUBERGER BERMAN REAL ESTATE SECURITIES INCOME FUND INC is a closed-end management investment company that invests mainly in securities issued by real estate companies, including real estate investment trusts (REITs). Its primary objective is to gain high current income with capital appreciation being the second. Under normal market conditions, the Fund invests at least 90% of its total assets in income-producing common equity securities, preferred securities, convertible securities and non-convertible debt securities issued by real estate companies, including real estate investment trusts ("REITs").
Senseonics Holdings Inc is a medical technology company. It is focused on the design, development, and commercialization of glucose monitoring system, which helps people to manage their diabetes community with differentiated, long-term implantable glucose management technology. Its products and services include a Continuous glucose monitoring system, Sensor, Smart transmitter, and Mobile app. The firm has a Glucose monitoring product segment. The majority of the revenue is generated outside of the United States.